AUDRA LAFLEUR: Open Payments
NPI 1063853968 · HOPKINTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,389 in 119 payments from 16 companies in 2025. Trend: 2023 $11,431 · 2024 $4,732 · 2025 $2,389
Food & beverage: $2,299Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $446 |
| ABBVIE INC. | 25 | $435 |
| MERZ NORTH AMERICA, INC. | 4 | $220 |
| Lilly USA, LLC | 11 | $209 |
| Arcutis Biotherapeutics, Inc. | 15 | $166 |
| Organon LLC | 8 | $158 |
| Galderma Laboratories, L.P. | 9 | $155 |
| Regeneron Healthcare Solutions, Inc. | 5 | $153 |
| Amgen Inc. | 5 | $121 |
| Novartis Pharmaceuticals Corporation | 5 | $91 |
Products named: TREMFYA, SKYRIZI, TALTZ, Zoryve, DUPIXENT, RINVOQ, OTEZLA, VTAMA.
Industry payments across MA — which companies pay providers there.
